Best for
Mobile

AzurRx BioPharma, Inc (AZRX) is a leading biotechnology business based in the US. It opened the day at $1.29 after a previous close of $1.26. During the day the price has varied from a low of $1.23 to a high of $1.29. The latest price was $1.265 (25 minute delay). AzurRx BioPharma is listed on the NASDAQ and employs 12 staff. All prices are listed in US Dollars.
Open | $1.29 |
---|---|
High | $1.29 |
Low | $1.23 |
Close | $1.265 |
Previous close | $1.26 |
Change | $0.005 |
Change % | 0.3968% |
Volume | 697,887 |
52-week range | $0.5709 - $2.5 |
---|---|
50-day moving average | $1.2581 |
200-day moving average | $1.055 |
Wall St. target price | $3.5 |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | $-0.903 |
Other fees may apply. Your capital is at risk.
Both exchange rates and share prices fluctuate in real time, so the costs presented here should be considered as a guide only. They do not incorporate stamp duty. Always refer to the platform itself for availability and pricing – which may differ from our information.
Platform | Platform fee | Min. initial deposit | Trading fee estimate | |
---|---|---|---|---|
![]() |
£0 | No minimum | £3.76 £94.30 total |
Capital at risk |
![]() |
£0 | $200 | £0.45 £90.99 total |
Capital at risk |
![]() |
£0 | £0.01 | £0.81 £91.34 total |
Capital at risk |
![]() |
£0 | £50 | £0.74 £91.28 total |
Capital at risk |
![]() |
£0 | £1 | £13.14 £103.68 total |
Capital at risk |
![]() |
£9.99 per month | No minimum | £9.63 £100.17 total |
Capital at risk |
![]() |
£36 per year | £20 | £10.92 £101.45 total |
Capital at risk |
Full comparison of share dealing platforms
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the last close of $1.265
1 week (2021-04-13) | 59.32% |
---|---|
1 month (2021-03-19) | -8.99% |
3 months (2021-01-20) | 37.26% |
6 months (2020-10-20) | 58.13% |
1 year (2020-04-20) | 93.13% |
---|---|
2 years (2019-04-18) | -48.79% |
3 years (2018-04-20) | -63.23% |
Gross profit TTM | $0 |
---|---|
Return on assets TTM | -151.38% |
Return on equity TTM | -3305.91% |
Profit margin | 0% |
Book value | $0.487 |
Market capitalisation | $59.7 million |
TTM: trailing 12 months
There are currently 2.2 million AzurRx BioPharma shares held short by investors – that's known as the "short interest". This figure is 226.2% up from 669,092 last month.
There are a few different ways that this level of interest in shorting AzurRx BioPharma shares can be evaluated.
AzurRx BioPharma's "short interest ratio" (SIR) is the quantity of AzurRx BioPharma shares currently shorted divided by the average quantity of AzurRx BioPharma shares traded daily (recently around 5.2 million). AzurRx BioPharma's SIR currently stands at 0.42. In other words for every 100,000 AzurRx BioPharma shares traded daily on the market, roughly 420 shares are currently held short.
However AzurRx BioPharma's short interest can also be evaluated against the total number of AzurRx BioPharma shares, or, against the total number of tradable AzurRx BioPharma shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case AzurRx BioPharma's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 AzurRx BioPharma shares in existence, roughly 30 shares are currently held short) or 0.0297% of the tradable shares (for every 100,000 tradable AzurRx BioPharma shares, roughly 30 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against AzurRx BioPharma.
Find out more about how you can short AzurRx BioPharma stock.
We're not expecting AzurRx BioPharma to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.
Over the last 12 months, AzurRx BioPharma's shares have ranged in value from as little as $0.5709 up to $2.5. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while AzurRx BioPharma's is 1.6551. This would suggest that AzurRx BioPharma's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Subscribe to trending stock alerts for a chance to win
Ever wondered how to buy shares in CorMedix? We explain how and compare a range of providers that can give you access to many brands, including CorMedix.
Ever wondered how to buy shares in Champions Oncology? We explain how and compare a range of providers that can give you access to many brands, including Champions Oncology.
Ever wondered how to buy shares in Calithera Biosciences? We explain how and compare a range of providers that can give you access to many brands, including Calithera Biosciences.
Ever wondered how to buy shares in Cabaletta Bio? We explain how and compare a range of providers that can give you access to many brands, including Cabaletta Bio.
Ever wondered how to buy shares in BioCryst Pharmaceuticals? We explain how and compare a range of providers that can give you access to many brands, including BioCryst Pharmaceuticals.
Ever wondered how to buy shares in Bioamber? We explain how and compare a range of providers that can give you access to many brands, including Bioamber.
Ever wondered how to buy shares in Aqua Metals? We explain how and compare a range of providers that can give you access to many brands, including Aqua Metals.
Ever wondered how to buy shares in AGNC Investment? We explain how and compare a range of providers that can give you access to many brands, including AGNC Investment.
Ever wondered how to buy shares in Acutus Medical? We explain how and compare a range of providers that can give you access to many brands, including Acutus Medical.
Ever wondered how to buy shares in Zix? We explain how and compare a range of providers that can give you access to many brands, including Zix.